Non-Alcoholic Steatohepatitis Suppliers & Manufacturers
-
Manufacturerbased in Cambridge, UNITED KINGDOM
CN Bio is a leading bioengineering company specialising in single and multi-organ microphysiological systems and innovative lab technologies. We aim to provide systems that generate clinically translatable data that can enhance the development of ...
In vitro Non-Alcoholic Steatohepatitis (NASH) Services
Our Non-Alcoholic Fatty Liver Disorder (NAFLD)/NASH in vitro Services offer a preclinical tool to test therapeutics in a human-relevant model, replicating key disease phenotypes including fibrosis and reporting ...
CONTACT SUPPLIER -
Manufacturerbased in Gaithersburg, MARYLAND (USA)
Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual ...
Model ALT-801 - Dual GLP-1/Glucagon Agonist For NASH
A peptide-based dual GLP-1/glucagon receptor agonist designed to treat the metabolic dysfunction that causes non-alcoholic steatohepatitis (NASH). NASH, the most severe form of ...
CONTACT SUPPLIER -
Manufacturerbased in Midlothian, VIRGINIA (USA)
G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
-
Technologybased in Suwon, SOUTH KOREA
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play ...
Model OGB21501 - Long-Acting Recombinant Protein
OGB21501 is a long-acting recombinant protein of GLP-1/GIP/GCG/FGF21 generated by applying our proprietory protein conjugation platform, UniStac, and it is a tetra-specific drug for the treatment of non-alcoholic ...
CONTACT SUPPLIER -
Manufacturerbased in Schlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
InSphero 3D InSight - Model NASH - Advanced 3D Human Liver Disease
The InSphero 3D InSight™ Human Liver NASH Model consists of an advanced microtissue co-culture of healthy primary human liver cells combined with specially formulated media and cocktails that induce the progression of NAFLD and NASH from ...
CONTACT SUPPLIER -
Manufacturerbased in Munich, GERMANY
Isarna Therapeutics was built on profound knowledge in antisense oligonucleotide design and therapeutic development of this innovative compound class. Today, Isarna is developing a portfolio of antisense therapies targeting an emerging therapeutic ...
-
Technologybased in Seoul, SOUTH KOREA
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...
-
Technologybased in Menlo Park, CALIFORNIA (USA)
CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to ...
CohBar - Model CB4211 - Biotechnology for Nonalcoholic Steatohepatitis (NASH) and Obesity
We believe CB4211 offers a differentiated approach to treating nonalcoholic steatohepatitis (NASH) and obesity. Is a novel and improved analog of MOTS-c, a naturally occurring mitochondrial derived peptide (MDP) that plays a key ...
CONTACT SUPPLIER -
Manufacturerbased in Sint-Denijs Westrem, BELGIUM
We are a commercial stage medical device company developing the alfapump® platform for the treatment of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. The alfapump®, is a fully ...
Liver Disease (Nash) and Ascites
Liver disease, a large and growing market globally. Cirrhosis is late-stage liver disease which occurs when scar tissue (fibrosis) replaces healthy tissue. Alcohol and viral hepatitis B and C are common causes of cirrhosis, although ...
CONTACT SUPPLIER -
Manufacturerbased in Heerlen, NETHERLANDS
DSM is a global purpose-led, science-based company specializing in Nutrition, Health & Sustainable Living. Our purpose is to create brighter lives for all. We achieve it by using all the scientific and innovation power at our disposal to tackle some ...
-
Manufacturerbased in Mapo, SOUTH KOREA
MD Healthcare contributes to being healthy through innovative healthcare solutions based on cutting edge science and technology. One of the most revolutionary advances in the biological sciences in recent years has been the realization that ...
-
Technologybased in Cambridge, MASSACHUSETTS (USA)
Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...
-
Technologybased in South San Francisco, CALIFORNIA (USA)
Superfluid’s platform technology is applicable to a wide variety of diseases. We are currently focused on Alzheimer’s Disease, where there are urgent medical needs. This minimally invasive approach eliminates the need for spinal taps and ...
-
Manufacturerbased in Loos, FRANCE
GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and chronic liver diseases. Our translational disease-driven research approach is based on strong expertise, featuring in-house knowledge of ...
Nitazoxanide in NASH-Induced Fibrosis
We are conducting a research program to develop an anti-fibrotic drug candidate, with a priority given to liver fibrosis. This program consists in a repositioning of Nitazoxanide, or NTZ*, that is being investigated for the treatment of fibrosis in ...
CONTACT SUPPLIER -
Software vendorbased in Boston, MASSACHUSETTS (USA)
At PathAI, we’re dedicated to improving patient outcomes with reliable AI-Powered technology and meaningful collaboration with biopharma, laboratories, and clinicians — aiming to provide patients with access to accurate diagnoses and effective ...
-
Manufacturerbased in Bentleyville, PENNSYLVANIA (USA)
Hoffman™ and Lamson™ brands of centrifugal blowers and exhausters are among the many compressed air and gas technologies manufactured by Gardner Denver Inc. Part of the Nash Division, they are American originals. Hoffman™ and Lamson™ brands have ...
-
Manufacturerbased in Cologne, GERMANY
LANXESS is one of the world's foremost suppliers of products for treating water and other liquid media. We have over 80 years of experience in water treatment and are a leader in the development and production of ion exchange resins and iron oxide ...
Good-Rite - Sodium Hydrogensulfide (NaSH)
Good-Rite Sodium Hydrogensulfide (NaSH) is a clear, aqueous solution that is produced and shipped in the United States. Good-Rite NaSH is used as a depilotory agent in the tanning industry; a key pulping chemical in the production of Kraft paper; a ...
CONTACT SUPPLIER -
Manufacturerbased in Shirley, NEW YORK (USA)
Over the last 10 years, Creative Biolabs has become a leader of recombinant antibody (rAb) discovery and manufacturing, providing high quality service to customers in academia and industry fields all over the world. Creative Biolabs was founded by ...
Nutritional Models of NAFLD/NASH
Nonalcoholic fatty liver disease (NAFLD), one of the most common chronic liver disease, is a condition characterized by abnormal excessive fat accumulation in the liver of a patient without a history of alcohol abuse. ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you